☆ 4.6 Letter

Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients

INTENSIVE CARE MEDICINE (2022)

Journal

INTENSIVE CARE MEDICINE

Volume 48, Issue 9, Pages 1245-1247

Publisher

SPRINGER

DOI: 10.1007/s00134-022-06797-9

Keywords

-

Categories

Critical Care Medicine

Funding

REACTing (REsearch and ACtion emergING infectious diseases) consortium
French Ministry of Health (PHRC) [20-0424]
National Institute Of General Medical Sciences of the National Institutes of Health [T32GM008440]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Psychiatric Rehabilitation Amidst COVID-19: Do Pandemic Restrictions Affect the Therapeutic Efficiency?

Joanna A. Smolarczyk-Kosowska, Pawel Debski, Anna R. Szczegielniak, Magdalena Piegza, Robert Pudlo

Summary: Due to COVID-19 sanitary restrictions, psychiatric rehabilitation programs had to adapt and modify therapeutic activities for patients. A study assessed the effectiveness of the modified rehabilitation program and found improvements in depression symptoms and quality of life among participants, but no significant benefits for anxiety symptoms.

APPLIED SCIENCES-BASEL (2022)

Add to Collection

Article Pharmacology & Pharmacy

Prediction of mortality and the development of critical illness in the course of COVID-19 with tertiary hospital data: vaccines? Critical illness scores? Mortality scores?

E. Guzel, K. Aydin, O. Baydar Toprak

Summary: The study aimed to investigate the risk factors for critical illness and mortality in COVID-19. The results showed that factors such as cough, creatinine, respiratory rate, and COVID-GRAM Critical Illness Score were associated with the development of critical illness, while vaccine status, blood urea nitrogen, respiratory rate, and COVID-GRAM-critical-illness score were associated with survival. The findings suggest that risk assessment using COVID-GRAM Critical Illness score and COVID-19 vaccination can reduce mortality risk.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2023)

Add to Collection

Article Clinical Neurology

Critical illness neuropathy in severe COVID-19: a case series

Tommaso Bocci, Laura Campiglio, Manuela Zardoni, Stefano Botta, Silvia Coppola, Elisabetta Groppo, Davide Chiumello, Alberto Priori

Summary: This study identified critical illness neuropathy (CIP) in COVID patients in the ICU. The presence of COVID-related CIP may have implications for functional recovery and rehabilitation strategies.

NEUROLOGICAL SCIENCES (2021)

Add to Collection

Review Immunology

Human genetic basis of severe or critical illness in COVID-19

Xiao-Shan Ji, Bin Chen, Bi Ze, Wen-Hao Zhou

Summary: COVID-19, caused by the novel SARS-CoV-2, has led to significant morbidity and mortality worldwide. The severity of the disease varies from asymptomatic to critical illness, and genetic variations in SARS-CoV-2 receptors and immune components have been found to be critical determinants of disease severity. Genetic background also plays a role in influencing the outcomes of COVID-19. Understanding the host genetic factors and viral interactions could contribute to personalized preventive measures and precision medicine strategies.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment

Mark C. Chappell

Summary: The current COVID-19 epidemic has had a significant health burden and has become the third leading cause of death in the United States. The virus binds to ACE2, a crucial enzyme in the renin-angiotensin system, leading to tissue infection and replication. This can result in reduced ACE2 activity and activation of the RAS, potentially exacerbating the inflammatory response and disease severity. Male patients and autoantibodies targeting components of the RAS may contribute to the greater severity of infection. This review critically evaluates the role of the activated RAS in COVID-19 and its potential impact on male patients.

CIRCULATION RESEARCH (2023)

Add to Collection

Article Medicine, General & Internal

Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge

Elie Azoulay, Matthieu Resche-Rigon, Bruno Megarbane, Danielle Reuter, Vincent Labbe, Alain Cariou, Guillaume Geri, Guillaume Van der Meersch, Achille Kouatchet, Olivier Guisset, Fabrice Bruneel, Jean Reignier, Virginie Souppart, Francois Barbier, Laurent Argaud, Jean-Pierre Quenot, Laurent Papazian, Bertrand Guidet, Guillaume Thiery, Kada Klouche, Olivier Lesieur, Alexandre Demoule, Christophe Guitton, Gilles Capellier, Bruno Mourvillier, Lucie Biard, Frederic Pochard, Nancy Kentish-Barnes

Summary: This study compared the risk of posttraumatic stress disorder among family members of patients with COVID-19-related acute respiratory distress syndrome (ARDS) versus ARDS from other causes. The findings showed that family members of COVID-19 ARDS patients had a significantly higher prevalence of PTSD symptoms compared to non-COVID-19 ARDS patients. The study concluded that COVID-19 ARDS was associated with a greater risk of PTSD symptoms among family members.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Multidisciplinary Sciences

Surviving critical COVID-19: How functionality, physical, mental and cognitive outcomes evolve?

Ana Teixeira-Vaz, Jose Afonso Rocha, Mafalda Oliveira, Tiago Simoes-Moreira, David Almeida e Reis, Ana Isabel Silva, Jose Artur Paiva

Summary: The purpose of this study was to analyze the long-term consequences of critical COVID-19, including physical, mental, cognitive, and functional impairments, and describe its evolution over time. A prospective cohort study was conducted, involving patients admitted to the ICU of a tertiary-care center between May 2020 and September 2021. The results showed that survivors of critical COVID-19 exhibited significant impairments in physical, mental, and cognitive domains 6 and 12 months after ICU discharge, despite showing some improvement over time. Additionally, their abilities in activities of daily living also improved.

PLOS ONE (2023)

Add to Collection

Article Infectious Diseases

Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives

Ziad A. Memish, Fahad Faqihi, Abdulrahman Alharthy, Saleh A. Alqahtani, Dimitrios Karakitsos

Summary: Since the outbreak at the end of 2019, COVID-19 has caused millions of cases and hundreds of thousands of deaths worldwide. Therapeutic plasma exchange (TPE) shows promise in managing life-threatening COVID-19, but its immunosuppressive effects and safety need further validation.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Add to Collection

Article Medicine, General & Internal

Exercise Limitation after Critical versus Mild COVID-19 Infection: A Metabolic Perspective

Maurice Joris, Joel Pincemail, Camille Colson, Jean Joris, Doriane Calmes, Etienne Cavalier, Benoit Misset, Julien Guiot, Gregory Minguet, Anne-Francoise Rousseau

Summary: Exercise limitation in COVID-19 survivors is due to altered metabolic profile, persistent inflammation, and oxidative stress. The study found that resting oxygen uptake was elevated and maximum effort was reached at low levels of workload and oxygen uptake. Metabolic efficiency was low and recovery profiles were delayed. Blood myeloperoxidase levels were elevated. Comparison with mid-disease COVID patients and obese patients showed similarities in some parameters between mid-disease patients and ICU group survivors, while obesity did not seem to contribute to exercise limitation.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Clinical Neurology

Neurological update: COVID-19

A. L. Ren, R. J. Digby, E. J. Needham

Summary: COVID-19 is primarily a respiratory disease, but can also lead to neurological complications. The main processes causing neurological damage include cerebrovascular disease, immunologically mediated neurological disorders, and the harmful effects of critical illness on the nervous system. While it is still uncertain if the virus directly invades the nervous system, the large number of infections at present suggests that nervous system infection may not be a significant issue.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Early Prediction Model for Critical Illness of Hospitalized COVID-19 Patients Based on Machine Learning Techniques

Yacheng Fu, Weijun Zhong, Tao Liu, Jianmin Li, Kui Xiao, Xinhua Ma, Lihua Xie, Junyi Jiang, Honghao Zhou, Rong Liu, Wei Zhang

Summary: This study conducted a retrospective multicenter analysis of data from 1,929 COVID-19 patients and proposed a risk prediction model based on laboratory findings. The study identified 28 indicators associated with critical illness in COVID-19 patients, which have significant implications for early identification of high-risk patients and optimizing the use of medical resources.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

Comparative analysis of anxiety/depression scores in COVID-19 patients with disease severity, sleep patterns, and certain laboratory test results

Zi-Qiang Meng, Qi Leng, Xu Wang, Chun-Hai Xu, Jing Xu, Yan Liu

Summary: This study explores the prevalence of anxiety and depression in COVID-19 patients and its correlation with disease severity, sleep patterns, lifestyle, and specific laboratory test results. It found that anxiety and depression are associated with poor sleep quality, smoking, and past medical history in COVID-19 patients. Additionally, there is a positive correlation between anxiety and depression, and the inflammatory index CRP is significantly increased in patients with bilateral lung infections.

ARCHIVES OF MEDICAL SCIENCE (2022)

Add to Collection

Article Multidisciplinary Sciences

Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19

Neha Paranjape, Lauren L. Staples, Christina Y. Stradwick, Herman Gene Ray, Ian J. Saldanha

Summary: Through studying 2,685 COVID-19 patients, factors like diabetes, coronary artery disease, chronic kidney disease, C-reactive protein, and lactate dehydrogenase were identified as significant risk factors for ICU transfer. A prediction model was developed with an AUC of 0.752 for the training dataset and 0.769 for the validation dataset.

PLOS ONE (2021)

Add to Collection

Article Medical Laboratory Technology

Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores

Renling Yao, Li Zhu, Jian Wang, Jiacheng Liu, Ruifei Xue, Leyang Xue, Longgen Liu, Chunyang Li, Haiyan Zhao, Juan Cheng, Songping Huang, Yang Li, Xiang-an Zhao, Chuanwu Zhu, Ming Li, Rui Huang, Chao Wu

Summary: NAFLD patients with NFS-determined advanced liver fibrosis are at higher risk of severe COVID-19. Concurrent diabetes and advanced liver fibrosis have been identified as independent risk factors for severe illness in COVID-19 patients with NAFLD.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Add to Collection

Article Medicine, General & Internal

Predicting Severe Disease and Critical Illness on Initial Diagnosis of COVID-19: Simple Triage Tools

Lutfi Ali S. Kurban, Sharina AlDhaheri, Abdulbaset Elkkari, Ramzi Khashkhusha, Shaikha AlEissaee, Amna AlZaabi, Mohamed Ismail, Omran Bakoush

Summary: This study developed and validated predictive models for severe and critical illness in symptomatic COVID-19 patients. The models identified age, serum lactate dehydrogenase (LDH), and serum albumin as important predictors. The models showed good discrimination and were validated in a separate cohort, indicating their potential utility in triaging and identifying high-risk patients.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Neuroimaging

Clinical outcome of patients with mild pre-stroke morbidity following endovascular treatment: a HERMES substudy

Rosalie McDonough, Johanna M. Ospel, Charles B. L. M. Majoie, Jeffrey L. Saver, Philip White, Diederik W. J. Dippel, Scott B. Brown, Andrew M. Demchuk, Tudor G. Jovin, Peter J. Mitchell, Serge Bracard, Bruce C. Campbell, Keith W. Muir, Michael D. Hill, Francis Guillemin, Mayank Goyal

Summary: This study examined the effect of pre-stroke functional levels on the outcome of endovascular therapy. The results showed that patients with mild pre-existing disability/symptoms had worse outcomes compared to those without disability. However, within the subgroup of patients with mild disability/symptoms, endovascular therapy still had a significant benefit.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Add to Collection

Article Infectious Diseases

Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination

Enagnon Kazali Alidjinou, Julie Demaret, Benedicte Corroyer-Simovic, Fanny Vuotto, Sophie Miczek, Julien Labreuche, Anne Goffard, Jacques Trauet, Daniela Lupau, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Annie Sobaszek, Didier Hober, Michael Hisbergues, Francois Puisieux, Brigitte Autran, Yazdan Yazdanpanah, Myriam Labalette, Guillaume Lefevre

Summary: The study investigated the serum neutralizing activity and T cell response against BA.1 and BA.2 sublineages before and after the administration of the booster vaccine in healthcare workers. The results showed that a low neutralizing activity was observed before the booster dose, but significant increases in neutralizing antibodies against Delta, BA.1, and BA.2 were observed after 3 months. Participants with recent infection maintained stable neutralizing antibody levels against Delta and BA.2, and showed an increase in neutralizing antibodies against BA.1.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Add to Collection

Article Virology

Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS-CoV-2 and monkeypox virus

Gregory Queromes, Emilie Frobert, Maude Bouscambert-Duchamp, Antoine Oblette, Martine Valette, Genevieve Billaud, Vanessa Escuret, Bruno Lina, Florence Morfin, Alexandre Gaymard

Summary: The diagnostics sector worldwide is facing an increasing demand due to the emergence of novel pathogens. In this study, seven commercialized diagnosis buffers, heat, and sodium dodecyl sulfate detergent were tested for their ability to inactivate SARS-CoV-2 and MPXV viruses. The results showed that all investigated methods were effective in inactivating SARS-CoV-2 and MPXV, providing valuable protocols for facilities in need of rapid and reliable solutions against these viruses.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Drug repurposing: From the discovery of a useful pharmacological effect to making the treatment available to the patient

Dominique Deplanque, Christine Fetro, Antoine Ferry, Philippe Lechat, Terence Beghyn, Claude Bernard, Antoine Bernasconi, Hugues Bienayme, Celine Cougoule, Joanie Del Bano, Claire Demiot, Benedicte Lebrun-Vignes

Summary: The repurposing of existing drugs for new indications can address unmet therapeutic needs, especially in the context of rare diseases and emergencies. However, there are challenges in accessing the drug and its data during preclinical and clinical stages, and clinical results may not guarantee marketing authorization or patient care. The round table proposed recommendations to overcome these obstacles, including the establishment of a well-funded public-private partnership to provide individualized support for projects until marketing application.

THERAPIE (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France

Jean-Sebastien Casalegno, Samantha Bents, John Paget, Yves Gillet, Dominique Ploin, Etienne Javouhey, Bruno Lina, Florence Morfin, Bryan T. Grenfell, Rachel Baker

Summary: The implementation of NPI during the COVID-19 pandemic had an impact on the circulation of RSV. A TSIR model was used to forecast the implications of this disruption on the future RSV epidemic. The model successfully captured the early start, peak timing, and end of the RSV epidemic, providing valuable information for mitigating the consequences of the outbreak.

JOURNAL OF GLOBAL HEALTH (2023)

Add to Collection

Article Anesthesiology

Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial

Matthieu Legrand, Rishi Kothari, Nicholas Fong, Nandini Palaniappa, David Boldt, Lee-Lynn Chen, Philip Kurien, Eilon Gabel, Jillene Sturgess-DaPrato, Michael O. Harhay, Romain Pirracchio, Michael P. Bokoch

Summary: This study conducted a multicentre, cluster-randomised, crossover feasibility and pilot trial in five hospitals in California. The study found that the effects of phenylephrine (PE) and norepinephrine (NE) infusion as first-line vasopressors were similar and did not significantly reduce the occurrence of postoperative complications.

BRITISH JOURNAL OF ANAESTHESIA (2023)

Add to Collection

Article Immunology

Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Matthieu Lafaurie, Sylvie Chevret, Jean-Paul Fontaine, Pierre Mongiat-Artus, Victoire de Lastours, Lelia Escaut, Stephane Jaureguiberry, Louis Bernard, Franck Bruyere, Caroline Gatey, Sophie Abgrall, Milagros Ferreyra, Hugues Aumaitre, Caroline Aparicio, Valerie Garrait, Vanina Meyssonnier, Anne Bourgarit-Durand, Amelie Chabrol, Emilie Piet, Jean-Philippe Talarmin, Marine Morrier, Etienne Canoui, Caroline Charlier, Manuel Etienne, Jerome Pacanowski, Nathalie Grall, Kristell Desseaux, Florence Empana-Barat, Isabelle Madeleine, Beatrice Bercot, Jean-Michel Molina, Agnes Lefort

Summary: This multicenter randomized, double-blind placebo-controlled noninferiority trial compared 7 days to 14 days of antibiotic treatment for febrile urinary tract infections (UTIs) in men. The study found that a 7-day treatment was inferior to a 14-day treatment. It is therefore not recommended for men with febrile UTIs to receive a 7-day antibiotic therapy.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Characteristics and outcomes of an international cohort of 600000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia Garcia Barrio, Joaquin Baruch, Abigail Beane, Lucille Blumberg, Fernando Bozza, Tessa Broadley, Aidan Burrell, Gail Carson, Barbara Wanjiru Citarella, Andrew Dagens, Emmanuelle A. Dankwa, Christl A. Donnelly, Jake Dunning, Loubna Elotmani, Martina Escher, Nataly Farshait, Jean-Christophe Goffard, Bronner P. Goncalves, Matthew Hall, Madiha Hashmi, Benedict Sim Lim Heng, Antonia Ho, Waasila Jassat, Miguel Pedrera Jimenez, Cedric Laouenan, Samantha Lissauer, Ignacio Martin-Loeches, France Mentre, Laura Merson, Ben Morton, Daniel Munblit, Nikita A. Nekliudov, Alistair D. Nichol, Budha Charan Singh Oinam, David Ong, Prasan Kumar Panda, Michele Petrovic, Mark G. Pritchard, Nagarajan Ramakrishnan, Grazielle Viana Ramos, Claire Roger, Oana Sandulescu, Malcolm G. Semple, Pratima Sharma, Louise Sigfrid, Emily C. Somers, Anca Streinu-Cercel, Fabio Taccone, Pavan Kumar Vecham, Bharath Kumar Tirupakuzhi Vijayaraghavan, Jia Wei, Evert-Jan Wils, Xin Ci Wong, Peter Horby, Amanda Rojek, Piero L. Olliaro, Ali Abbas

Summary: This study analyzed demographic features, treatments, and clinical outcomes of hospitalized COVID-19 patients in 52 countries from January 2020 to January 2022. Age and male sex were associated with a higher risk of death. Symptoms, co-morbidities, and treatments were associated with clinical outcomes. This comprehensive international study provides valuable information for prioritizing treatment for COVID-19 patients at higher risk of death.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Add to Collection

Article Immunology

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19

Hakim Hocini, Aurelie Wiedemann, Fabiola Blengio, Cecile Lefebvre, Minerva Cervantes-Gonzalez, Emile Foucat, Pascaline Tisserand, Mathieu Surenaud, Severin Coleon, Melanie Prague, Lydia Guillaumat, Corinne Krief, Craig Fenwick, Cedric Laouenan, Lila Bouadma, Jade Ghosn, Giuseppe Pantaleo, Rodolphe Thiebaut, Yves Levy, Laurent Abel, Amal Abrous, Claire Andrejak, Francois Angoulvant, Delphine Bachelet, Marie Bartoli, Sylvie Behilill, Marine Beluze, Krishna Bhavsar, Anissa Chair, Charlotte Charpentier, Leo Chenard, Catherine Chirouze, Sandrine Couffin-cadiergues, Camille Couffignal, Nathalie D. E. Castro, Marie-Pierre Debray, Dominique Deplanque, Diane Descamps, Alpha Diallo, Fernanda Dias D. A. Silva, Celine Dorival, Xavier Duval, Philippine Eloy, Vincent Enouf, Helene Esperou, Marina Esposito-farese, Manuel Etienne, Aline-Marie Florence, Alexandre Gaymard, Tristan Gigante, Morgane Gilg, Francois Goehringer, Jeremie Guedj, Ikram Houas, Isabelle Hoffmann, Jean-Sebastien Hulot, Salma Jaafoura, Simon Jamard, Ouifiya Kafif, Antoine Khalil, Nadhem Lafhej, Samira Laribi, Minh Le, Quentin LE. Hingrat, Soizic LE. Mestre, Sophie Letrou, Bruno Lina, Guillaume Lingas, Denis Malvy, France Mentre, Hugo Mouquet, Nadege Neant, Christelle Paul, Aurelie Papadopoulos, Ventzislava Petrov-sanchez, Gilles Peytavin, Valentine Piquard, Olivier Picone, Manuel Rosa-calatrava, Benedicte Rossignol, Patrick Rossignol, Carine Roy, Marion Schneider, Coralie Tardivon, Jean-Francois Timsit, Sarah Tubiana, Sylvie Van Der Werf, Benoit Visseaux

Summary: This study investigated the immunological dysfunction underlying the persistence of symptoms in individuals after severe COVID-19 infection. The analysis of cytokines, cell phenotypes, antibodies, and gene expression profiles revealed persistent abnormalities even up to 6 months after hospital discharge, including high levels of activation markers, T-cell abnormalities, decreased antibodies, and upregulation of genes related to blood components. These findings suggest the need for extended clinical follow-up and preventive measures for patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Virology

SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results

Delphine Parraud, Anne-Lise Maucotel, Maude Bouscambert, Florence Morfin, Laurent Bitker, Christian Chidiac, Nathalie De Castro, Emilie Frobert, Alexandre Gaymard

Summary: Qualitative SARS-CoV-2 antigen assays based on immunochromatography are useful for mass diagnosis of COVID-19, even though their sensitivity is poor in comparison with RT-PCR assays. Quantitative assays can improve antigenic test performance and allow testing with different specimens. Urinary antigen detection could be part of the strategy for the late diagnosis and prognostic evaluation of COVID-19, given the ease and painlessness of sampling and the duration of antigen excretion in this biological compartment.

VIRUSES-BASEL (2023)

Add to Collection

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

Add to Collection

Article Urology & Nephrology

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

Marina Wainstein, Nicholas Spyrison, Danyang Dai, Moji Ghadimi, Jonathan S. Chavez-Iniguez, Lilia Rizo-Topete, Barbara Wanjiru Citarella, Laura Merson, Jason D. Pole, Rolando Claure-Del Granado, David W. Johnson, S. Shrapnel

Summary: There is a lack of research on the relationship between COVID-19 and acute kidney injury (AKI) in low- and low-middle income countries. This study found that AKI incidence was highest in LLMIC, with lower rates of dialysis and poorer patient outcomes.

KIDNEY INTERNATIONAL REPORTS (2023)

Add to Collection

Article Medicine, General & Internal

Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death

Florent Sauve, Sreekala Nampoothiri, Sophie A. Clarke, Daniela Fernandois, Caio Fernando Ferreira Coelho, Julie Dewisme, Edouard G. Mills, Gaetan Ternier, Ludovica Cotellessa, Cristina Iglesias-Garcia, Helge Mueller-Fielitz, Thibaud Lebouvier, Romain Perbet, Vincent Florent, Marc Baroncini, Ariane Sharif, June Ereno-Orbea, Maria Mercado-Gomez, Asis Palazon, Virginie Mattot, Florence Pasquier, Sophie Catteau-Jonard, Maria Martinez-Chantar, Erik Hrabovszky, Merce Jourdain, Dominique Deplanque, Annamaria Morelli, Giulia Guarnieri, Laurent Storme, Cyril Robil, Francois Trottein, Ruben Nogueiras, Markus Schwaninger, Pascal Pigny, Julien Poissy, Konstantina Chachlaki, Claude-Alain Maurage, Paolo Giacobini, Waljit Dhillo, S. Rasika, Vincent Prevot

Summary: There may be a connection between post-COVID symptoms and the loss of GnRH, which could lead to cognitive decline and other neurological symptoms. Research suggests that the decrease in testosterone levels in some COVID-19 patients may originate from the hypothalamus and be associated with cognitive or neurological symptoms. Infection of the olfactory sensory neurons and hypothalamic glia by the SARS-CoV-2 virus could result in abnormalities of the GnRH system. Furthermore, fetal olfactory and GnRH neurons may be susceptible to viral infection.

EBIOMEDICINE (2023)

Add to Collection

Article Multidisciplinary Sciences

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

Danye Lee, Jeremie Le Pen, Ahmad Yatim, Beihua Dong, Yann Aquino, Masato Ogishi, Remi Pescarmona, Estelle Talouarn, Darawan Rinchai, Peng Zhang, Magali Perret, Zhiyong Liu, Iolanda Jordan, Sefika Elmas Bozdemir, Gulsum Iclal Bayhan, Camille Beaufils, Lucy Bizien, Aurelie Bisiaux, Weite Lei, Milena Hasan, Jie Chen, Christina Gaughan, Abhishek Asthana, Valentina Libri, Joseph M. Luna, Fabrice Jaffre, H. -Heinrich Hoffmann, Eleftherios Michailidis, Marion Moreews, Yoann Seeleuthner, Kaya Bilguvar, Shrikant Mane, Carlos Flores, Yu Zhang, Andres A. Arias, Rasheed Bailey, Agatha Schlueter, Baptiste Milisavljevic, Benedetta Bigio, Tom Le Voyer, Marie Materna, Adrian Gervais, Marcela Moncada-Velez, Francesca Pala, Tomi Lazarov, Romain Levy, Anna-Lena Neehus, Jeremie Rosain, Jessica Peel, Yi-Hao Chan, Marie-Paule Morin, Rosa Maria Pino-Ramirez, Serkan Belkaya, Lazaro Lorenzo, Jordi Anton, Selket Delafontaine, Julie Toubiana, Fanny Bajolle, Victoria Furnado, Marta L. DeDiego, Nadhira Fidouh, Flore Rozenberg, Jordi Perez-Tur, Shuibing Chen, Todd Evans, Frederic Geissmann, Pierre Lebon, Susan R. Weiss, Damien Bonnet, Xavier Duval, Qiang Pan-Hammarstroem, Anna M. Planas, Isabelle Meyts, Filomeen Haerynck, Aurora Pujol, Vanessa Sancho-Shimizu, Clifford L. Dalgard, Jacinta Bustamante, Anne Puel, Stephanie Boisson-Dupuis, Bertrand Boisson, Tom Maniatis, Qian Zhang, Paul Bastard, Luigi Notarangelo, Vivien Beziat, Rebeca Perez de Diego, Carlos Rodriguez-Gallego, Helen C. Su, Richard P. Lifton, Emmanuelle Jouanguy, Aurelie Cobat, Laia Alsina, Sevgi Keles, Elie Haddad, Laurent Abel, Alexandre Belot, Lluis Quintana-Murci, Charles M. Rice, Robert H. Silverman, Shen-Ying Zhang, Jean-Laurent Casanova

SCIENCE (2023)

Add to Collection

Article Anesthesiology

Postoperative thrombotic events following major surgery in patients with a history of COVID-19: a retrospective cohort analysis of commercially insured beneficiaries in the USA

Daniel V. Lazzareschi, Yanting Luo, Nicholas Fong, John Boscardin, Matthieu Legrand, Catherine L. Chen

Summary: This study aimed to evaluate the synergistic risk of postoperative thrombosis in patients with a history of COVID-19 who undergo major surgery. The findings showed no evidence of a synergistic thrombotic risk from previous COVID-19 in patients who underwent selected major surgery.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.